Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

The CYP2D6*4 polymorphism affects breast cancer survival in tamoxifen users.

The CYP2D6*4 polymorphism affects breast cancer survival in tamoxifen users. Breast Cancer Res Treat. 2009 Nov; 118(1):125-30.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.